Stay updated on Sotorasib in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotorasib in KRAS G12C NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical-trial record for a neoadjuvant sotorasib study in resectable KRAS G12C-mutated NSCLC is displayed, with its study design, eligibility criteria, and outcomes. The record indicates that the study was withdrawn because of slow accrual.
    Difference
    38%
    Check dated 2026-11-09T13:56:39.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The 403 Forbidden message and its Home button disappear, and the site revision changes from v3.7.2 to v3.8.0.
    Difference
    0.6%
    Check dated 2026-11-02T15:45:30.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    An NIH banner announces a website terminology transition, stating that some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-26T16:59:03.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T17:50:28.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T18:22:23.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page instead of the study record content, indicating that the resource is restricted or unavailable.
    Difference
    16%
    Check dated 2026-09-21T22:45:43.000Z thumbnail image

Stay in the know with updates to Sotorasib in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.